Meeder Asset Management Inc. Sells 4,343 Shares of Integer Holdings Corp (NYSE:ITGR)

Share on StockTwits

Meeder Asset Management Inc. decreased its position in shares of Integer Holdings Corp (NYSE:ITGR) by 85.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 725 shares of the medical equipment provider’s stock after selling 4,343 shares during the quarter. Meeder Asset Management Inc.’s holdings in Integer were worth $61,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC boosted its stake in Integer by 118.9% in the 1st quarter. FMR LLC now owns 950,210 shares of the medical equipment provider’s stock worth $71,664,000 after purchasing an additional 516,080 shares during the period. Emerald Advisers LLC boosted its stake in Integer by 8.7% in the 2nd quarter. Emerald Advisers LLC now owns 408,969 shares of the medical equipment provider’s stock worth $34,321,000 after purchasing an additional 32,586 shares during the period. Emerald Mutual Fund Advisers Trust boosted its stake in Integer by 8.1% in the 2nd quarter. Emerald Mutual Fund Advisers Trust now owns 355,030 shares of the medical equipment provider’s stock worth $29,794,000 after purchasing an additional 26,634 shares during the period. Geode Capital Management LLC boosted its stake in Integer by 7.7% in the 4th quarter. Geode Capital Management LLC now owns 351,636 shares of the medical equipment provider’s stock worth $26,814,000 after purchasing an additional 25,002 shares during the period. Finally, Rockefeller Capital Management L.P. boosted its stake in Integer by 0.5% in the 1st quarter. Rockefeller Capital Management L.P. now owns 317,485 shares of the medical equipment provider’s stock worth $23,945,000 after purchasing an additional 1,675 shares during the period. Institutional investors own 97.51% of the company’s stock.

Shares of ITGR opened at $72.13 on Wednesday. The company has a market cap of $2.37 billion, a PE ratio of 18.98 and a beta of 0.96. The company has a current ratio of 2.42, a quick ratio of 1.41 and a debt-to-equity ratio of 0.78. Integer Holdings Corp has a 12-month low of $67.72 and a 12-month high of $92.61. The stock has a 50-day moving average price of $80.71 and a 200-day moving average price of $78.97.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $1.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.06 by $0.17. The company had revenue of $314.20 million for the quarter, compared to analysts’ expectations of $318.50 million. Integer had a return on equity of 13.31% and a net margin of 15.73%. Integer’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the firm posted $1.06 EPS. As a group, analysts predict that Integer Holdings Corp will post 4.4 earnings per share for the current year.

In other Integer news, Director Jean M. Hobby sold 6,000 shares of Integer stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $80.19, for a total value of $481,140.00. Following the transaction, the director now directly owns 15,475 shares of the company’s stock, valued at approximately $1,240,940.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.24% of the stock is owned by insiders.

Several research analysts have commented on ITGR shares. ValuEngine downgraded Integer from a “hold” rating to a “sell” rating in a research note on Friday, August 2nd. Argus cut their target price on Integer from $90.00 to $4.29 and set an “average” rating for the company in a research note on Wednesday, June 5th. They noted that the move was a valuation call. Finally, Northcoast Research restated a “buy” rating on shares of Integer in a research note on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $72.57.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Further Reading: What is Depreciation?

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

OTCMKTS:PROSY  Now Covered by Analysts at Barclays
OTCMKTS:PROSY Now Covered by Analysts at Barclays
Exagen  Coverage Initiated by Analysts at Cowen
Exagen Coverage Initiated by Analysts at Cowen
Square  Receives New Coverage from Analysts at UBS Group
Square Receives New Coverage from Analysts at UBS Group
$248.92 Million in Sales Expected for ExlService Holdings, Inc.  This Quarter
$248.92 Million in Sales Expected for ExlService Holdings, Inc. This Quarter
XcelToken Plus  Tops 24-Hour Volume of $3,040.00
XcelToken Plus Tops 24-Hour Volume of $3,040.00
PDATA  Reaches 24-Hour Volume of $8,278.00
PDATA Reaches 24-Hour Volume of $8,278.00


© 2006-2019 Ticker Report